2Sweet RL,Gibbs RS(eds).Infectious diseases of the female genital tract.Baltimore:Williams & Wilkins,1995.252-317.
3Kind C,Rudin C, Siegrist CA,et al. Prevention of vertical HIV transmission: additive protective effect of elective cesarean section and zidovudine prophylaxis. Swiss neonatal HIV study group. AIDS,1998,12:205-210.
4Grobman WA,Garcia PM.The cost effectiveness of voluntary intrapartum ripid human immunodeficiency virus testing for women without adequate prenatal care.Am J Obstet Gynecol,1999,181:1062-1071.
3Reshi P,Lone IM. Human immunodeficiency virus and pregnancy[J].Archives of Gynecology and Obstetrics,2010,(05):781-792.
4Magder LS,Mofenson L,Paul ME. Risk factors for in utero and intrapartum transmission of HIV[J].Journal of Acquired Immune Deficiency Syndromes,2005,(01):87-95.doi:10.1097/00126334-200501010-00016.
5Abrams EJ,Wiener J,Carter R. Maternal health factors and early pediatric antiretroviral therapy influence the rate of perinatal HIV-1 disease progression in children[J].Aids,2003,(06):867-877.
6Jackson DJ,Goga AE,Doherty T. An update on HIV and infant feeding issues in developed and developing countries[J].Journal of Obstetric,Gynecologic,and Neonatal Nursing,2009,(02):219-229.
7World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants:recommendations for a public health approach[M].Switzerland:WHO Press,2010.20-53.
8World Health Organization. Antiretroviral therapy for HIV infection in infant and children:towards universal access recommendations for a public health approach[M].Switzerland:WHO Press,2010.22-27.
9Gaillard P,Verhofstede C,Mwanyumba F. Exposure to HIV-1 during delivery and mother-to-child transmission[J].Aids,2000,(15):2341-2348.
10Mark S,Murphy KE,Read S. HIV mother-to-child transmission,mode of delivery,and duration of rupture of membranes:experience in the current era[J].Infectious Diseases in Obstetrics and Gynecology,2012.267969.
